Kolageri, S. , Hemanth , S. and Parit, M. 2022. In-silico ADME prediction and molecular docking study of novel benzimidazole-1,3,4-oxadiazole derivatives as CYP51 inhibitors for antimicrobial activity. Journal of Applied Pharmaceutical Research. 10, 3 (Sep. 2022), 28-38. DOI:https://doi.org/10.18231/j.joapr.2022.10.3.28.38.